The Cooper Companies, Inc. (COO) Debt to Assets Ratio: 0.22%
The debt to assets ratio for The Cooper Companies, Inc. (COO) is 0.22% as of Sunday, June 14, 2026.
COO Debt to Assets Ratio Metrics
DEBT TO ASSETS RATIO
0.22%
COO Competitors' Debt to Assets Ratio
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 0.22% |
| Solventum Corporation (SOLV) | $13.66B | 0.35% |
| Align Technology, Inc. (ALGN) | $12.52B | 0.02% |
| Baxter International Inc. (BAX) | $10.77B | 0.50% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.42% |
| Hologic, Inc. (HOLX) | $16.97B | 0.29% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 0.43% |
| Tempus AI, Inc. (TEM) | $8.35B | 0.36% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 0.14% |
| Moderna, Inc. (MRNA) | $19.80B | 0.16% |
Leverage Ratios Comparison
Debt/Assets
0.2%
Debt/Equity
0.34
Current Ratio
1.89
Interest Coverage
6.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
- Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
- Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
- Both measure leverage but from different perspectives
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
The Cooper Companies, Inc. Debt to Assets Ratio Formula & Definition
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Debt to Assets Ratio FAQ
- What is the debt to assets ratio for The Cooper Companies, Inc. (COO)?
- The debt to assets ratio for COO stock is 0.22%.
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White